Related Experiment Video
Updated: Jul 20, 2026

07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
[PET in thyroid cancers]
Jean-Noël Talbot1, Françoise Montravers, Nassima Younsi
1Service de Médecine Nucléaire, Hôpital Tenon, AP-HP; Université Pierre et Marie Curie, Paris. jean-noel.talbot@tnn.ap-hop-paris.fr
Summary
Fluorodeoxyglucose-positron emission tomography (FDG PET) aids in detecting thyroid cancer recurrence after surgery. Early FDG PET imaging may predict survival outcomes in thyroid cancer patients.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiology
Background:
- FDG PET can incidentally detect thyroid cancer during evaluation for other malignancies.
- Current guidelines do not recommend FDG PET for initial thyroid nodule assessment due to low specificity; ultrasonography and fine needle biopsy are preferred.
- The role of FDG PET in preoperative staging of thyroid cancer remains under investigation.
Purpose of the Study:
- To evaluate the utility of FDG PET in the detection and management of thyroid cancer.
- To assess the role of FDG PET in the follow-up of patients with differentiated thyroid adenocarcinoma and medullary carcinoma.
- To explore the potential of FDOPA PET in detecting recurrent thyroid cancer.
Main Methods:
- Review of existing literature and clinical data regarding FDG PET and FDOPA PET in thyroid cancer.
- Analysis of FDG PET's performance in detecting incidental thyroid cancers, staging, and recurrence monitoring.
- Comparison of FDG PET with other imaging modalities like iodine-123 and iodine-131 scintigraphy.
Main Results:
- FDG PET is valuable for detecting thyroid cancer recurrence when thyroglobulin levels rise and iodine-131 scintigraphy is negative in adenocarcinoma patients.
- Early detection of FDG-avid foci is a significant predictor of reduced survival in thyroid cancer.
- FDG PET shows superior performance in detecting residual medullary thyroid carcinoma compared to other scintigraphic methods, especially with rising CEA levels.
- FDOPA PET demonstrates promising sensitivity for occult recurrence, as suggested by case reports.
Conclusions:
- FDG PET is a useful tool for detecting recurrent thyroid cancer, particularly in differentiated adenocarcinoma and medullary carcinoma follow-up.
- Wider and earlier application of FDG PET may improve prognostic assessment and potentially guide treatment decisions.
- FDOPA PET warrants further investigation for its role in identifying occult thyroid cancer recurrence.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

